Use of Mutated Self-Cleaving 2A Peptides as a Molecular Rheostat to Direct Simultaneous Formation of Membrane and Secreted Anti-HIV Immunoglobulins

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Yu, Kenneth K ^a,b   Aguilar, Kiefer ^a   Tsai, Jonathan ^a   Galimidi, Rachel ^a   Gnanapragasam, Priyanthi ^a   Yang, Lili ^a   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LENTIVIRUS VECTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ALTERNATIVE RNA SPLICING; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; GENE MUTATION; GENE THERAPY; GENETIC MANIPULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LENTIVIRINAE; LYMPHOPOIESIS; STEM CELL;

CALCIUM; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC VECTORS; HEK293 CELLS; HIV; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOLOGIC TECHNIQUES; LENTIVIRUS; MODELS, BIOLOGICAL; NEUTRALIZATION TESTS; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, B-CELL; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84870325153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050438     Document Type: Article

References (40)

1. McHeyzer-Williams LJ, McHeyzer-Williams MG, (2005) Antigen-specific memory B cell development. Annu Rev Immunol 23: 487-513.
2. Burrows PD, Cooper MD, (1993) B-cell development in man. Curr Opin Immunol 5: 201-206.
3. Chen J, Alt FW, (1993) Gene rearrangement and B-cell development. Curr Opin Immunol 5: 194-200.
4. Kitamura D, Rajewsky K, (1992) Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 356: 154-156.
5. Kitamura D, Roes J, Kuhn R, Rajewsky K, (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
6. Wagner SD, Williams GT, Larson T, Neuberger MS, Kitamura D, et al. (1994) Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res 22: 1389-1393.
7. Spanopoulou E, Roman CA, Corcoran LM, Schlissel MS, Silver DP, et al. (1994) Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev 8: 1030-1042.
8. Young F, Ardman B, Shinkai Y, Lansford R, Blackwell TK, et al. (1994) Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev 8: 1043-1057.
9. Alt FW, Bothwell AL, Knapp M, Siden E, Mather E, et al. (1980) Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends. Cell 20: 293-301.
10. Early P, Rogers J, Davis M, Calame K, Bond M, et al. (1980) Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell 20: 313-319.
11. Rogers J, Early P, Carter C, Calame K, Bond M, et al. (1980) Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin mu chain. Cell 20: 303-312.
12. Peterson ML, Gimmi ER, Perry RP, (1991) The developmentally regulated shift from membrane to secreted mu mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency. Mol Cell Biol 11: 2324-2327.
13. Peterson ML, (2007) Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development. Immunol Res 37: 33-46.
14. de Felipe P, (2004) Skipping the co-expression problem: the new 2A "CHYSEL" technology. Genet Vaccines Ther 2: 13.
15. Szymczak AL, Vignali DA, (2005) Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther 5: 627-638.
16. de Felipe P, Hughes LE, Ryan MD, Brown JD, (2003) Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. J Biol Chem 278: 11441-11448.
17. Doronina VA, de Felipe P, Wu C, Sharma P, Sachs MS, et al. (2008) Dissection of a co-translational nascent chain separation event. Biochem Soc Trans 36: 712-716.
18. Doronina VA, Wu C, de Felipe P, Sachs MS, Ryan MD, et al. (2008) Site-specific release of nascent chains from ribosomes at a sense codon. Mol Cell Biol 28: 4227-4239.
19. Atkins JF, Wills NM, Loughran G, Wu CY, Parsawar K, et al. (2007) A case for "StopGo": reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go). RNA 13: 803-810.
20. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, et al. (2001) The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 82: 1027-1041.
21. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, et al. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82: 1013-1025.
22. Ryan MD, Drew J, (1994) Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 13: 928-933.
23. Luo XM, Maarschalk E, O'Connell RM, Wang P, Yang L, et al. (2009) Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood 113: 1422-1431.
24. Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, et al. (2005) Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 11: 932-940.
25. O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, et al. (2010) Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. PLoS ONE 5: e12009.
26. Zhang Z, Wang YH, Zemlin M, Findley HW, Bridges SL, et al. (2003) Molecular mechanism of serial VH gene replacement. Ann N Y Acad Sci 987: 270-273.
27. Tweeddale ME, Lim B, Jamal N, Robinson J, Zalcberg J, et al. (1987) The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. Blood 69: 1307-1314.
28. Klein JS, Gnanapragasam PN, Galimidi RP, Foglesong CP, West AP Jr, et al. (2009) Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc Natl Acad Sci U S A 106: 7385-7390.
29. Zhang Z, (2007) VH replacement in mice and humans. Trends Immunol 28: 132-137.
30. Galli G, Guise J, Tucker PW, Nevins JR, (1988) Poly(A) site choice rather than splice site choice governs the regulated production of IgM heavy-chain RNAs. Proc Natl Acad Sci U S A 85: 2439-2443.
31. Galli G, Guise JW, McDevitt MA, Tucker PW, Nevins JR, (1987) Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development. Genes Dev 1: 471-481.
32. Peterson ML, Perry RP, (1986) Regulated production of mu m and mu s mRNA requires linkage of the poly(A) addition sites and is dependent on the length of the mu s-mu m intron. Proc Natl Acad Sci U S A 83: 8883-8887.
33. Peterson ML, Perry RP, (1989) The regulated production of mu m and mu s mRNA is dependent on the relative efficiencies of mu s poly(A) site usage and the c mu 4-to-M1 splice. Mol Cell Biol 9: 726-738.
34. Takagaki Y, Manley JL, (1998) Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol Cell 2: 761-771.
35. Takagaki Y, Seipelt RL, Peterson ML, Manley JL, (1996) The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87: 941-952.
36. Kumar M, Keller B, Makalou N, Sutton RE, (2001) Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12: 1893-1905.
37. Joseph A, Zheng JH, Chen K, Dutta M, Chen C, et al. (2010) Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody. J Virol 84: 6645-6653.
38. Grupp SA, Mitchell RN, Schreiber KL, McKean DJ, Abbas AK, (1995) Molecular mechanisms that control expression of the B lymphocyte antigen receptor complex. J Exp Med 181: 161-168.
39. Tolar P, Hanna J, Krueger PD, Pierce SK, (2009) The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity 30: 44-55.
40. Harrison PT, Hutchinson MJ, Allen JM, (1994) A convenient method for the construction and expression of GPI-anchored proteins. Nucleic Acids Res 22: 3813-3814.